Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée (CRAV.PA) Stock Competitors & Peer Comparison
See (CRAV.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Banks - Regional Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CRAV.PA | €129.98 | -1.53% | 160.1M | 12.19 | €10.91 | +2.65% |
| BNP.PA | €83.30 | +2.85% | 94.1B | 8.30 | €10.29 | +8.64% |
| ACA.PA | €16.36 | +2.70% | 50.2B | 7.61 | €2.18 | +6.63% |
| GLE.PA | €64.24 | +4.02% | 48.1B | 9.70 | €6.80 | +2.58% |
| KBC.BR | €108.70 | +4.02% | 43.6B | 12.64 | €8.69 | +2.64% |
| XBBDC.MC | €3.24 | +3.85% | 34.5B | 9.31 | €0.35 | +0.94% |
| A5G.IR | €8.94 | -0.83% | 19.3B | 9.72 | €0.93 | +5.20% |
| BIRG.IR | €15.70 | +1.72% | 14.8B | 13.57 | €1.15 | +3.40% |
| BCP.LS | €0.86 | +3.75% | 12.9B | 12.47 | €0.07 | +3.44% |
| VLK.AS | €58.90 | +3.70% | 2.5B | 17.03 | €3.47 | +7.02% |
Stock Comparison
CRAV.PA vs BNP.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, BNP.PA has a market cap of 94.1B. Regarding current trading prices, CRAV.PA is priced at €129.98, while BNP.PA trades at €83.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas BNP.PA's P/E ratio is 8.30. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to BNP.PA's ROE of +0.09%. Regarding short-term risk, CRAV.PA is less volatile compared to BNP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check BNP.PA's competition here
CRAV.PA vs ACA.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, ACA.PA has a market cap of 50.2B. Regarding current trading prices, CRAV.PA is priced at €129.98, while ACA.PA trades at €16.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas ACA.PA's P/E ratio is 7.61. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to ACA.PA's ROE of +0.10%. Regarding short-term risk, CRAV.PA is more volatile compared to ACA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check ACA.PA's competition here
CRAV.PA vs GLE.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, GLE.PA has a market cap of 48.1B. Regarding current trading prices, CRAV.PA is priced at €129.98, while GLE.PA trades at €64.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas GLE.PA's P/E ratio is 9.70. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to GLE.PA's ROE of +0.10%. Regarding short-term risk, CRAV.PA is less volatile compared to GLE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check GLE.PA's competition here
CRAV.PA vs KBC.BR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, KBC.BR has a market cap of 43.6B. Regarding current trading prices, CRAV.PA is priced at €129.98, while KBC.BR trades at €108.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas KBC.BR's P/E ratio is 12.64. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to KBC.BR's ROE of +0.13%. Regarding short-term risk, CRAV.PA is more volatile compared to KBC.BR. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check KBC.BR's competition here
CRAV.PA vs XBBDC.MC Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, XBBDC.MC has a market cap of 34.5B. Regarding current trading prices, CRAV.PA is priced at €129.98, while XBBDC.MC trades at €3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas XBBDC.MC's P/E ratio is 9.31. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to XBBDC.MC's ROE of +0.14%. Regarding short-term risk, CRAV.PA is less volatile compared to XBBDC.MC. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check XBBDC.MC's competition here
CRAV.PA vs A5G.IR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, A5G.IR has a market cap of 19.3B. Regarding current trading prices, CRAV.PA is priced at €129.98, while A5G.IR trades at €8.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas A5G.IR's P/E ratio is 9.72. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to A5G.IR's ROE of +0.15%. Regarding short-term risk, CRAV.PA is less volatile compared to A5G.IR. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check A5G.IR's competition here
CRAV.PA vs BIRG.IR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, BIRG.IR has a market cap of 14.8B. Regarding current trading prices, CRAV.PA is priced at €129.98, while BIRG.IR trades at €15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas BIRG.IR's P/E ratio is 13.57. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to BIRG.IR's ROE of +0.10%. Regarding short-term risk, CRAV.PA is less volatile compared to BIRG.IR. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check BIRG.IR's competition here
CRAV.PA vs BCP.LS Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, BCP.LS has a market cap of 12.9B. Regarding current trading prices, CRAV.PA is priced at €129.98, while BCP.LS trades at €0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas BCP.LS's P/E ratio is 12.47. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to BCP.LS's ROE of +0.17%. Regarding short-term risk, CRAV.PA is more volatile compared to BCP.LS. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check BCP.LS's competition here
CRAV.PA vs VLK.AS Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, VLK.AS has a market cap of 2.5B. Regarding current trading prices, CRAV.PA is priced at €129.98, while VLK.AS trades at €58.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas VLK.AS's P/E ratio is 17.03. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to VLK.AS's ROE of +0.12%. Regarding short-term risk, CRAV.PA is more volatile compared to VLK.AS. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check VLK.AS's competition here
CRAV.PA vs PTSB.IR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, PTSB.IR has a market cap of 1.6B. Regarding current trading prices, CRAV.PA is priced at €129.98, while PTSB.IR trades at €2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas PTSB.IR's P/E ratio is 22.85. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to PTSB.IR's ROE of +0.05%. Regarding short-term risk, CRAV.PA is more volatile compared to PTSB.IR. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check PTSB.IR's competition here
CRAV.PA vs IL0A.IR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, IL0A.IR has a market cap of 1.3B. Regarding current trading prices, CRAV.PA is priced at €129.98, while IL0A.IR trades at €2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas IL0A.IR's P/E ratio is 5.34. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to IL0A.IR's ROE of +0.05%. Regarding short-term risk, CRAV.PA is less volatile compared to IL0A.IR. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check IL0A.IR's competition here
CRAV.PA vs CAF.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CAF.PA has a market cap of 916.9M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CAF.PA trades at €113.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CAF.PA's P/E ratio is 13.46. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CAF.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is more volatile compared to CAF.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CAF.PA's competition here
CRAV.PA vs MLCFM.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, MLCFM.PA has a market cap of 733.4M. Regarding current trading prices, CRAV.PA is priced at €129.98, while MLCFM.PA trades at €1,280.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas MLCFM.PA's P/E ratio is 14.72. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to MLCFM.PA's ROE of +0.12%. Regarding short-term risk, CRAV.PA is more volatile compared to MLCFM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check MLCFM.PA's competition here
CRAV.PA vs CRBP2.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRBP2.PA has a market cap of 394.2M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRBP2.PA trades at €27.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRBP2.PA's P/E ratio is 6.11. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRBP2.PA's ROE of +0.04%. Regarding short-term risk, CRAV.PA is more volatile compared to CRBP2.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CRBP2.PA's competition here
CRAV.PA vs CNF.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CNF.PA has a market cap of 260.5M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CNF.PA trades at €16.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CNF.PA's P/E ratio is 4.65. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CNF.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is more volatile compared to CNF.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CNF.PA's competition here
CRAV.PA vs CIV.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CIV.PA has a market cap of 231.8M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CIV.PA trades at €104.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CIV.PA's P/E ratio is 10.31. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CIV.PA's ROE of +0.02%. Regarding short-term risk, CRAV.PA is less volatile compared to CIV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check CIV.PA's competition here
CRAV.PA vs CMO.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CMO.PA has a market cap of 164.2M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CMO.PA trades at €103.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CMO.PA's P/E ratio is 8.06. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CMO.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is more volatile compared to CMO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CMO.PA's competition here
CRAV.PA vs BNB.BR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, BNB.BR has a market cap of 160.8M. Regarding current trading prices, CRAV.PA is priced at €129.98, while BNB.BR trades at €396.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas BNB.BR's P/E ratio is -0.04. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to BNB.BR's ROE of -0.19%. Regarding short-term risk, CRAV.PA is less volatile compared to BNB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check BNB.BR's competition here
CRAV.PA vs CAT31.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CAT31.PA has a market cap of 147M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CAT31.PA trades at €113.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CAT31.PA's P/E ratio is 7.94. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CAT31.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is less volatile compared to CAT31.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check CAT31.PA's competition here
CRAV.PA vs CCN.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CCN.PA has a market cap of 141.9M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CCN.PA trades at €134.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CCN.PA's P/E ratio is 9.53. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CCN.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is more volatile compared to CCN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CCN.PA's competition here
CRAV.PA vs CRLA.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRLA.PA has a market cap of 133.9M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRLA.PA trades at €79.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRLA.PA's P/E ratio is 7.95. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRLA.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is less volatile compared to CRLA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check CRLA.PA's competition here
CRAV.PA vs CRTO.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRTO.PA has a market cap of 127M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRTO.PA trades at €127.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRTO.PA's P/E ratio is 12.06. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRTO.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is less volatile compared to CRTO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check CRTO.PA's competition here
CRAV.PA vs CRSU.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRSU.PA has a market cap of 118.1M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRSU.PA trades at €200.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRSU.PA's P/E ratio is 8.43. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRSU.PA's ROE of +0.03%. Regarding short-term risk, CRAV.PA is more volatile compared to CRSU.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CRSU.PA's competition here
CRAV.PA vs CRLO.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRLO.PA has a market cap of 97M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRLO.PA trades at €93.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRLO.PA's P/E ratio is 12.40. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRLO.PA's ROE of +0.02%. Regarding short-term risk, CRAV.PA is less volatile compared to CRLO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CRAV.PA.Check CRLO.PA's competition here
CRAV.PA vs CRAP.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, CRAP.PA has a market cap of 96.1M. Regarding current trading prices, CRAV.PA is priced at €129.98, while CRAP.PA trades at €139.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas CRAP.PA's P/E ratio is 7.80. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to CRAP.PA's ROE of +0.04%. Regarding short-term risk, CRAV.PA is more volatile compared to CRAP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check CRAP.PA's competition here
CRAV.PA vs MLGRC.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, MLGRC.PA has a market cap of 56M. Regarding current trading prices, CRAV.PA is priced at €129.98, while MLGRC.PA trades at €23.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas MLGRC.PA's P/E ratio is 74.38. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to MLGRC.PA's ROE of +0.02%. Regarding short-term risk, CRAV.PA is more volatile compared to MLGRC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check MLGRC.PA's competition here
CRAV.PA vs KN.PA Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, KN.PA has a market cap of 0. Regarding current trading prices, CRAV.PA is priced at €129.98, while KN.PA trades at €4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas KN.PA's P/E ratio is 25.01. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to KN.PA's ROE of +0.01%. Regarding short-term risk, CRAV.PA is more volatile compared to KN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check KN.PA's competition here
CRAV.PA vs DD7E.IR Comparison April 2026
CRAV.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CRAV.PA stands at 160.1M. In comparison, DD7E.IR has a market cap of 0. Regarding current trading prices, CRAV.PA is priced at €129.98, while DD7E.IR trades at €23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CRAV.PA currently has a P/E ratio of 12.19, whereas DD7E.IR's P/E ratio is N/A. In terms of profitability, CRAV.PA's ROE is +0.02%, compared to DD7E.IR's ROE of +0.13%. Regarding short-term risk, CRAV.PA is more volatile compared to DD7E.IR. This indicates potentially higher risk in terms of short-term price fluctuations for CRAV.PA.Check DD7E.IR's competition here